Universal false discovery rate estimation methodology for genome-wide association studies.
Karl Forner1, Marc Lamarine, Mickaël Guedj
1Merck Serono, Geneva Research Center, Geneva, Switzerland.
Human Heredity
|December 13, 2007
Summary
This study introduces a universal method for estimating the False Discovery Rate (FDR) in genome-wide association studies (GWAS). The new approach is more accurate than existing methods, especially for non-parametric estimations in genetic marker selection.
Area of Science:
- Genetics
- Statistical genomics
- Bioinformatics
Background:
- Genome-wide association studies (GWAS) identify genetic markers differentiating populations.
- Large-scale genotyping generates vast data, leading to multiple testing challenges.
- Existing False Discovery Rate (FDR) methods are often ill-suited for GWAS designs.
Purpose of the Study:
- To develop a universal methodology for estimating FDR in GWAS.
- To provide a practical approach applicable to any study design and statistic.
- To improve the selection of significant genetic markers in association studies.
Main Methods:
- Developed a universal methodology using a single global probability value per single nucleotide polymorphism (SNP).
- Benchmarked the algorithm on simulated data for performance evaluation.
- Applied the method to experimental genotyping data from Multiple Sclerosis case-control studies.
Main Results:
- The proposed methodology outperforms previous methods, particularly in non-parametric estimation scenarios.
- Demonstrated the practical utility and applicability across diverse GWAS designs.
- Successfully applied to real-world genotyping data for disease association studies.
Conclusions:
- The universal FDR estimation method offers a robust and adaptable solution for GWAS.
- Enhances the reliability of identifying significant genetic markers in complex diseases.
- Provides a valuable tool for genetic association research and marker selection.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
02:54Evolutionary Relationships through Genome Comparisons
Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...